Rare diseases
Investigational molecules
Locations
290 conditions with trials, the busiest first
1 641 trials across Europe, recruiting first
Study on Guselkumab for Patients with Moderate-to-Severe Plaque Psoriasis
GermanyStudy on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
BelgiumStudy on the Safety and Effectiveness of Bezuclastinib for Patients with Advanced Systemic Mastocytosis
AustriaStudy on MAS825 for Patients with Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
CzechiaStudy Comparing Subcutaneous and Intravenous Ocrelizumab for Patients with Multiple Sclerosis
CzechiaStudy on Leflunomide and Hydroxychloroquine for Patients with Primary Sjögren's Syndrome
The NetherlandsStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids
BulgariaStudy of Enpatoran in Adults with Systemic Lupus Erythematosus (SLE) and Cutaneous Lupus Erythematosus (CLE)
BulgariaLong-Term Safety Study of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis
AustriaLong-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata
CzechiaStudy on the Effectiveness and Safety of Budesonide and Formoterol Fumarate for Patients with Poorly Controlled Asthma
GermanyStudy on Riliprubart for Preventing and Treating Antibody-Mediated Rejection in Adult Kidney Transplant Patients
FranceThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
